Literature DB >> 18646010

Genome-scale identification of UDP-GlcNAc-dependent pathways.

Ken S Lau1, Sofia Khan, James W Dennis.   

Abstract

Metabolite flux to UDP-GlcNAc and Golgi N-glycan biosynthesis regulates surface residency of glycoprotein receptors and transporters, and thus sensitivities of cells to extracellular cues. Salvage of GlcNAc increases UDP-GlcNAc and branching of N-glycans progressively, but displays an optimum for cell proliferation and bulk endocytosis in mouse NMuMG and human HEK293T epithelial cells. In this report, we measured global changes in gene expression in low and high GlcNAc-supplemented cells. Genes upregulated by high GlcNAc included the EGF and TGF-beta signaling pathways and cell cycle checkpoint, while downregulated genes indicated lower metabolic activity. Genes increased or decreased by high GlcNAc were assessed by transfecting cells with small interfering RNA (siRNA) and measuring effects on three phenotypes: proliferation and bulk endocytosis, and beta1,6GlcNAc-branching of N-glycans. siRNA targeting LGALS3, WBSCR17, PHF3, SDC2 and CTNNAL1 partially reversed the GlcNAc-induced phenotypes, suggesting a role for galectin-3/N-glycans, proteoglycans, O-glycans, and junctional cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18646010     DOI: 10.1002/pmic.200800208

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

Review 2.  Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle.

Authors:  Irving Omar Estévez-García; Verónica Cordoba-Gonzalez; Eleazar Lara-Padilla; Abel Fuentes-Toledo; Ramcés Falfán-Valencia; Rafael Campos-Rodríguez; Edgar Abarca-Rojano
Journal:  J Physiol Biochem       Date:  2014-03-07       Impact factor: 4.158

3.  A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational opportunities and barriers.

Authors:  Rebecca D Levit; W Robert Taylor
Journal:  J Cardiovasc Transl Res       Date:  2011-08-18       Impact factor: 4.132

4.  A putative polypeptide N-acetylgalactosaminyltransferase/Williams-Beuren syndrome chromosome region 17 (WBSCR17) regulates lamellipodium formation and macropinocytosis.

Authors:  Yoshiaki Nakayama; Naosuke Nakamura; Sayoko Oki; Masaki Wakabayashi; Yasushi Ishihama; Ayumi Miyake; Nobuyuki Itoh; Akira Kurosaka
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

5.  Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.

Authors:  Michael Boyce; Isaac S Carrico; Anjali S Ganguli; Seok-Ho Yu; Matthew J Hangauer; Sarah C Hubbard; Jennifer J Kohler; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

6.  A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on (13)C mass isotopologue profiles under non-steady-state conditions.

Authors:  Hunter N B Moseley; Andrew N Lane; Alex C Belshoff; Richard M Higashi; Teresa W M Fan
Journal:  BMC Biol       Date:  2011-05-31       Impact factor: 7.431

7.  Structural variants in genes associated with human Williams-Beuren syndrome underlie stereotypical hypersociability in domestic dogs.

Authors:  Bridgett M vonHoldt; Emily Shuldiner; Ilana Janowitz Koch; Rebecca Y Kartzinel; Andrew Hogan; Lauren Brubaker; Shelby Wanser; Daniel Stahler; Clive D L Wynne; Elaine A Ostrander; Janet S Sinsheimer; Monique A R Udell
Journal:  Sci Adv       Date:  2017-07-19       Impact factor: 14.136

Review 8.  O-GlcNAc Modification and Its Role in Diabetic Retinopathy.

Authors:  Chengzhi Liu; Wenkang Dong; Jun Li; Ying Kong; Xiang Ren
Journal:  Metabolites       Date:  2022-08-05

9.  N-acetylglucosamine (GlcNAc) functions in cell signaling.

Authors:  James B Konopka
Journal:  Scientifica (Cairo)       Date:  2012-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.